BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37457230)

  • 1. Assessing the reporting quality of adult neuro-oncology protocols, abstracts, and trials: Adherence to the SPIRIT and CONSORT statements.
    Suppree JS; Patel A; Keshwara SM; Krishna ST; Gillespie CS; Richardson GE; Mustafa MA; Hart S; Islim AI; Jenkinson MD; Millward CP
    Neurooncol Pract; 2023 Aug; 10(4):391-401. PubMed ID: 37457230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles: Primary Results of 2 Randomized Trials.
    Speich B; Mann E; Schönenberger CM; Mellor K; Griessbach AN; Dhiman P; Gandhi P; Lohner S; Agarwal A; Odutayo A; Puebla I; Clark A; Chan AW; Schlussel MM; Ravaud P; Moher D; Briel M; Boutron I; Schroter S; Hopewell S
    JAMA Netw Open; 2023 Jun; 6(6):e2317651. PubMed ID: 37294569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
    Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
    Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
    Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
    Trials; 2015 Sep; 16():417. PubMed ID: 26385379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions.
    Duarte RV; Bresnahan R; Copley S; Eldabe S; Thomson S; North RB; Baranidharan G; Levy RM; Taylor RS;
    Neuromodulation; 2022 Oct; 25(7):1045-1049. PubMed ID: 35088759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.
    Espinasse A; Solovyeva O; Dimairo M; Weir C; Jaki T; Mander A; Kightley A; Evans J; Lee S; Bedding A; Hopewell S; Rantell K; Liu R; Chan AW; De Bono J; Yap C
    BMJ Open; 2023 Mar; 13(3):e068173. PubMed ID: 36990492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting Quality of Randomized Controlled Trials of Periodontal Diseases in Journal Abstracts-A Cross-sectional Survey and Bibliometric Analysis.
    Kumar S; Mohammad H; Vora H; Kar K
    J Evid Based Dent Pract; 2018 Jun; 18(2):130-141.e22. PubMed ID: 29747793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.
    Tunn R; Boutron I; Chan AW; Collins GS; Hróbjartsson A; Moher D; Schulz KF; de Beyer JA; Hansen Nejstgaard C; Østengaard L; Hopewell S
    J Clin Epidemiol; 2024 May; 169():111309. PubMed ID: 38428538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has the quality of abstracts for randomised controlled trials improved since the release of Consolidated Standards of Reporting Trial guideline for abstract reporting? A survey of four high-profile anaesthesia journals.
    Can OS; Yilmaz AA; Hasdogan M; Alkaya F; Turhan SC; Can MF; Alanoglu Z
    Eur J Anaesthesiol; 2011 Jul; 28(7):485-92. PubMed ID: 21037480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the CONSORT checklist for abstracts improve the quality of reports of randomized controlled trials on clinical pathways?
    Cui Q; Tian J; Song X; Yang K
    J Eval Clin Pract; 2014 Dec; 20(6):827-33. PubMed ID: 24916891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the online impact of reporting guidelines for randomised trial reports and protocols: a cross-sectional web-based data analysis of CONSORT and SPIRIT initiatives.
    Orduña-Malea E; Alonso-Arroyo A; Ontalba-Ruipérez JA; Catalá-López F
    Scientometrics; 2023; 128(1):407-440. PubMed ID: 36274792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the completeness of the reporting of abstracts since the publication of the CONSORT extension for abstracts: an evaluation of randomized controlled trial in ten nursing journals.
    He Y; Zhang R; Shan W; Yin Y; Zhang X; Zhang Y; Wang X
    Trials; 2023 Jun; 24(1):423. PubMed ID: 37349754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the quality of reporting of randomised controlled trials in otorhinolaryngologic literature - adherence to the CONSORT statement.
    Peters JP; Hooft L; Grolman W; Stegeman I
    PLoS One; 2015; 10(3):e0122328. PubMed ID: 25793517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has the reporting quality of published randomised controlled trial protocols improved since the SPIRIT statement? A methodological study.
    Tan ZW; Tan AC; Li T; Harris I; Naylor JM; Siebelt M; van Tiel J; Pinheiro M; Harris L; Chamberlain K; Adie S
    BMJ Open; 2020 Aug; 10(8):e038283. PubMed ID: 32847919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Natural Language Processing Tool to Generate the CONSORT Reporting Checklist for Randomized Clinical Trials.
    Wang F; Schilsky RL; Page D; Califf RM; Cheung K; Wang X; Pang H
    JAMA Netw Open; 2020 Oct; 3(10):e2014661. PubMed ID: 33030549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to the Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Randomized Controlled Trials Related to Mandibular Third Molars.
    Kshirsagar K; Bhate K; Shete A; Kakodkar P
    J Oral Maxillofac Surg; 2021 Jun; 79(6):1207-1213. PubMed ID: 33651976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.